Urinary cyclic adenosine 3',5'-monophosphate response in McCune-Albright syndrome: cyclical evidence for altered renal adenylate cyclase activity
Zung A, Chalew SA, Schwindinger WF, Levine MA, Phillip M, Jara A, Counts DR, Kowarski AA,
Journal of Pediatric Endocrinology & Metabolism (JPEM)
1995
80
3576-3581
en
The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design
Increased mitogenic responsiveness of Swiss 3T3 cells expressing constitutively active GsAlpha
Zachary I, Masters SB, Bourne HR,
Biochem Biophys Res Commun
1990
168
1184-1193
en
Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune-Albright syndrome
Zacharin M, O'Sullivan M,
J Pediatr
2000
137
403-409
en
Osteoporosis pseudoglioma syndrome: treatment of spinal osteoporosis with intravenous bisphosphonates
Zacharin M, Cundy TO,
J Pediatr
2000
137
410-415
en
Bisphosphonate therapy for polyostotic syndrome
Zacharin M,
First International Conference on Children's Bone Health
1999
Abst P-28
en
Use of pamidronate in the management of acute cancer-related hypercalcaemia in children
Young G, Shende A,
Med Pediatr Oncol
1998
30
117-121
en
Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis
Yoshimoto K, Iwahana H, Fukuda A, Sano T, Itakura M,
Cancer
1993
72
1386-1393
en
Characteristics of gsp-positive growth hormone-secreting pituitary tumors in Korean acromegalic patients
Yang I, Park S, Ryu M, Woo J, Kim J, Kim Y , Choi Y,
Eur J Endocrinol
1996
134
720-726
en
Increased IL-6 production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome
